FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jantina Kettenes-van den Bosch

Research Profile

Chemicals & Drugs

Procedures

Phenomena

Magnetic Resonance Spectroscopy

Concepts & Ideas

Occupations

Genes & Molecular Sequences

Amino Acid Sequences

Activities & Behaviors

Quality Control

Co-author Network

Publications

TOP 3
Birgit Romberg; J Jantina Kettenes-van den Bosch; Tom de Vringer; Gert Storm; Wim E Hennink
1H NMR spectroscopy as a tool for determining the composition of poly(hydroxyethyl-L-asparagine)-coated liposomes.
Monique W J den Brok; Bastiaan Nuijen; J Jantina Kettenes-van den Bosch; Mies J van Steenbergen; Josie N Buluran; Michael D Harvey; Charles K Grieshaber; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311.
Birgit Romberg; Josbert M Metselaar; Tom deVringer; Kei Motonaga; J Jantina Kettenes-van den Bosch; Christien Oussoren; Gert Storm; Wim E Hennink
Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jantina Kettenes-van den Bosch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Birgit Romberg; J Jantina Kettenes-van den Bosch; Tom de Vringer; Gert Storm; Wim E Hennink
1H NMR spectroscopy as a tool for determining the composition of poly(hydroxyethyl-L-asparagine)-coated liposomes.
Bioconjugate chemistry 2006;17(3):860-4.
2005: Monique W J den Brok; Bastiaan Nuijen; J Jantina Kettenes-van den Bosch; Mies J van Steenbergen; Josie N Buluran; Michael D Harvey; Charles K Grieshaber; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311.
PDA journal of pharmaceutical science and technology / PDA 2005;59(5):285-97.
2005: Birgit Romberg; Josbert M Metselaar; Tom deVringer; Kei Motonaga; J Jantina Kettenes-van den Bosch; Christien Oussoren; Gert Storm; Wim E Hennink
Enzymatic degradation of liposome-grafted poly(hydroxyethyl L-glutamine).
Bioconjugate chemistry 2005;16(4):767-74.
2002: Jioji N Tabudravu; Marcel Jaspars; Linda A Morris; J Jantina Kettenes-van den Bosch; Nigel Smith
Two distinct conformers of the cyclic heptapeptide phakellistatin 2 isolated from the fijian marine sponge stylotellaaurantium.
The Journal of organic chemistry 2002;67(24):8593-601.
2002: Marjan Bouma; Bastiaan Nuijen; Gianni Sava; Alberto Perbellini; Antonella Flaibani; Mies J van Steenbergen; Herre Talsma; J Jantina Kettenes-van den Bosch; Auke Bult; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-A.
International journal of pharmaceutics 2002;248(1-2):247-59.
2002: Pauline J Vollmerhaus; F W Alexander Tempels; J Jantina Kettenes-van den Bosch; albert heck
Molecular interactions of glycopeptide antibiotics investigated by affinity capillary electrophoresis and bioaffinity electrospray ionization-mass spectrometry.
Electrophoresis 2002;23(6):868-79.
2002: E A A M Vernooij; J Jantina Kettenes-van den Bosch; Willy J M Underberg; Daan J A Crommelin
Chemical hydrolysis of DOTAP and DOPE in a liposomal environment.
Journal of controlled release : official journal of the Controlled Release Society 2002;79(1-3):299-303.
2001: SJ de Jong; Stefaan C De Smedt; Jo Demeester; Cornelus F van Nostrum; J Jantina Kettenes-van den Bosch; Wim E Hennink
Biodegradable hydrogels based on stereocomplex formation between lactic acid oligomers grafted to dextran.
Journal of controlled release : official journal of the Controlled Release Society 2001;72(1-3):47-56.
2001: SJ de Jong; B van Eerdenbrugh; Cornelus F van Nostrum; J Jantina Kettenes-van den Bosch; Wim E Hennink
Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior.
Journal of controlled release : official journal of the Controlled Release Society 2001;71(3):261-75.
2000: Alwin D R Huitema; Matthijs M Tibben; Thomas Kerbusch; J Jantina Kettenes-van den Bosch; Sjoerd Rodenhuis; Jos H Beijnen
Simple and selective determination of the cyclophosphamide metabolite phosphoramide mustard in human plasma using high-performance liquid chromatography.
Journal of chromatography. B, Biomedical sciences and applications 2000;745(2):345-55.
2000: Bastiaan Nuijen; Marjan Bouma; RE Henrar; Pablo Floriano; José Jimeno; Herre Talsma; J Jantina Kettenes-van den Bosch; albert heck; Auke Bult; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine.
PDA journal of pharmaceutical science and technology / PDA 2000;54(3):193-208.
1999: E A A M Vernooij; C A Gentry; J N Herron; Daan J A Crommelin; J Jantina Kettenes-van den Bosch
1H NMR quantification of poly(ethylene glycol)-phosphatidylethanolamine in phospholipid mixtures.
Pharmaceutical research 1999;16(10):1658-61.
1999: C Sluiter; J Jantina Kettenes-van den Bosch; E Hop; OA van der Houwen; Willy J M Underberg; Auke Bult
Degradation study of the investigational anticancer drug clanfenur.
International journal of pharmaceutics 1999;185(2):227-35.
1999: Rolf W Sparidans; J Jantina Kettenes-van den Bosch; Olaf van Tellingen; B Nuyen; RE Henrar; José Jimeno; Glynn Faircloth; Pablo Floriano; K L Rinehart; Jos H Beijnen
Bioanalysis of aplidine, a new marine antitumoral depsipeptide, in plasma by high-performance liquid chromatography after derivatization with trans-4-hydrazino-2-stilbazole.
Journal of chromatography. B, Biomedical sciences and applications 1999;729(1-2):43-53.
1999: R van Gijn; Olaf van Tellingen; E Haverkate; J Jantina Kettenes-van den Bosch; Auke Bult; Jos H Beijnen
Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice.
Investigational new drugs 1999;17(1):29-41.
1998: Thomas Kerbusch; Alwin D R Huitema; J Jantina Kettenes-van den Bosch; HJ Keizer; J Ouwerkerk; J de Kraker; Jos H Beijnen
High-performance liquid chromatographic determination of stabilized 4-hydroxyifosfamide in human plasma and erythrocytes.
Journal of chromatography. B, Biomedical sciences and applications 1998;716(1-2):275-84.
1998: J D Jonkman-de Vries; Hilde Rosing; Herre Talsma; RE Henrar; J Jantina Kettenes-van den Bosch; Auke Bult; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11].
Investigational new drugs 1998;16(2):99-111.
1997: Douwe de Boer; L P Tan; P Gorter; R M van de Wal; J Jantina Kettenes-van den Bosch; E A de Bruijn; Robert A A Maes
Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.
Journal of mass spectrometry : JMS 1997;32(11):1236-46.
1997: J D Jonkman-de Vries; B J Van den Bemt; Wim W ten Bokkel Huinink; Willy J M Underberg; J Jantina Kettenes-van den Bosch; RE Henrar; Auke Bult; Jos H Beijnen
Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur.
PDA journal of pharmaceutical science and technology / PDA 1997;51(2):89-95.
1997: Hilde Rosing; Virginie M M Herben; D M van Gortel-van Zomeren; E Hop; J Jantina Kettenes-van den Bosch; Wim W ten Bokkel Huinink; Jos H Beijnen
Isolation and structural confirmation of N-desmethyl topotecan, a metabolite of topotecan.
Cancer chemotherapy and pharmacology 1997;39(6):498-504.
1996: A J Van den Berg; S F Horsten; J Jantina Kettenes-van den Bosch; CJ Beukelman; B H Kroes; Bas Leeflang; R P Labadie
Podacycline A and B, two cyclic peptides in the latex of Jatropha podagrica.
Phytochemistry 1996;42(1):129-33.
1996: S F Horsten; A J van den Berg; J Jantina Kettenes-van den Bosch; Bas Leeflang; R P Labadie
Cyclogossine A: a novel cyclic heptapeptide isolated from the latex of Jatropha gossypifolia.
Planta medica 1996;62(1):46-50.
1996: J D Jonkman-de Vries; J Jantina Kettenes-van den Bosch; RE Henrar; Auke Bult; Jos H Beijnen
Purity determinations in the bulk drug of the novel indoloquinone antitumor agent EO9.
Investigational new drugs 1996;14(2):181-91.
1995: JL Reubsaet; Jos H Beijnen; Auke Bult; E Hop; R Vermaas; Y Kellekule; J Jantina Kettenes-van den Bosch; Willy J M Underberg
Structural identification of the degradation products of the antitumor peptide antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11).
Analytical chemistry 1995;67(23):4431-6.
1995: A J van den Berg; S F Horsten; J Jantina Kettenes-van den Bosch; B H Kroes; CJ Beukelman; Bas Leeflang; R P Labadie
Curcacycline A--a novel cyclic octapeptide isolated from the latex of Jatropha curcas L.
FEBS letters 1995;358(3):215-8.
1994: Olaf van Tellingen; A L Sonneveldt; Jos H Beijnen; Willem Nooijen; J Jantina Kettenes-van den Bosch; C Versluis; Auke Bult
Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography.
Cancer chemotherapy and pharmacology 1994;33(5):425-34.
1994: J D Jonkman-de Vries; H Talsma; RE Henrar; J Jantina Kettenes-van den Bosch; Auke Bult; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9.
Cancer chemotherapy and pharmacology 1994;34(5):416-22.
1994: J D Jonkman-de Vries; M J de Graaff-Teulen; RE Henrar; J Jantina Kettenes-van den Bosch; Auke Bult; Jos H Beijnen
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).
Investigational new drugs 1994;12(4):303-14.